Skip to content

Veradermics MANE Temporary Equity, Shares Subscribed but Unissued, Subscriptions Receivable

Temporary Equity, Shares Subscribed but Unissued, Subscriptions Receivable at other companies

Asset Entities logo
Asset EntitiesASST
4.4M
Schering-Plough logo
Schering-PloughSGP
0
Prospect Capital logo
Prospect CapitalPSEC
70.2M-1.3%
Perella Weinberg Partners logo
Perella Weinberg PartnersPWP
21.9M-16.3%
Schering-Plough logo
Schering-PloughSGP
0-100%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
0-100%

Other financials

Income statement

See full
Operating income-$29.9M-131%
Net income-$27.2M-120%
EPS (diluted)-$1.32+93.3%

Balance sheet

See full
Cash & equivalents$168.4M+419%
Total debt$4.0K
Total equity$390.6M+744%
Total assets$397.4M

Cash flow

See full
Operating cash flow-$21.2M-59.0%
CapEx--100%
Free cash flow-$21.2M-58.7%

Valuation

See full
Market cap$4.9B+296%

Returns & leverage

See full
Return on equity-28.7%
Current ratio59.1×

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable.

The official record: Veradermics ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's temporary equity, shares subscribed but unissued, subscriptions receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veradermics 's temporary equity, shares subscribed but unissued, subscriptions receivable?
Veradermics (MANE) reported temporary equity, shares subscribed but unissued, subscriptions receivable of $0 in Q1 2026.
How has Veradermics 's temporary equity, shares subscribed but unissued, subscriptions receivable changed year-over-year?
Veradermics 's temporary equity, shares subscribed but unissued, subscriptions receivable decreased by 100.0% year-over-year, from $3.49M to $0.
What is the long-term trend for Veradermics 's temporary equity, shares subscribed but unissued, subscriptions receivable?
Over 2 years (2023 to 2025), Veradermics 's temporary equity, shares subscribed but unissued, subscriptions receivable has grown at a 43.8% compound annual growth rate (CAGR), from $894K to $1.85M.
What does temporary equity, shares subscribed but unissued, subscriptions receivable mean?
This represents equity instruments that have been subscribed to by investors but for which shares have not yet been formally issued. It acts as a bridge between capital commitments and finalized equity issuance. This metric provides insight into pending capital inflows and potential future dilution.